About
Dosage Form Development
Areas of Focus
Categories
Contract ManufacturingContract ManufacturingContract ManufacturingContract ManufacturingContract ResearchContract ManufacturingContract ManufacturingDrug Delivery & FormulationContract ManufacturingContract Manufacturing
Team (33)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
0
As Collaborator
4
Total Enrollment
653
By Phase
PHASE3: 2PHASE1: 1PHASE4: 1
By Status
COMPLETED: 2RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06383273Collaborator
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
PHASE3Recruiting
528 participants
Started: May 1, 2024 · Completed: Jan 31, 2025
NCT03272165Collaborator
Single Ascending Dose Study of MEDI1341 in Healthy Volunteers
PHASE1Completed
50 participants
Started: Oct 17, 2017 · Completed: Mar 31, 2021
NCT02200029Collaborator
Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption
PHASE3Completed
75 participants
Started: Jun 30, 2014 · Completed: Feb 28, 2015
NCT02009410Collaborator
A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2
PHASE4Withdrawn
Started: Nov 30, 2013 · Completed: Aug 31, 2014
Locations (1)
Headquarters
Schorndorf, Germany
Map
Loading map...